Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
BMJ Open|August 28, 2023
Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European expertsMilou A Hogervorst, Mathias Møllebæk, Rick A Vreman, et al.Emerging Infectious Diseases|April 3, 2002
A European study on the relationship between antimicrobial use and antimicrobial resistanceStef L A M Bronzwaer, Otto Cars, Udo Buchholz, et al.Health Policy (Amsterdam, Netherlands)|February 24, 2015
European collaboration on relative effectiveness assessments: What is needed to be successful?Sarah Kleijnen, Wil Toenders, Folkert de Groot, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision MakingMarc L Berger, Harold Sox, Richard J Willke, et al.Pharmacoepidemiology and Drug Safety|September 16, 2017
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision makingMarc L Berger, Harold Sox, Richard J Willke, et al.European Journal of Cancer (Oxford, England : 1990)|July 20, 2012
Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The NetherlandsMargreet G Franken, Chantal W M van Gils, Jennifer G Gaultney, et al.Seminars in Arthritis and Rheumatism|March 31, 2024
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023Beverley Shea, Jordi Pardo Pardo, Shawna Grosskleg, et al.Journal of Comparative Effectiveness Research|March 2, 2023
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision makingBertalan Németh, Maria Kamusheva, Zornitsa Mitkova, et al.Health Research Policy and Systems|July 3, 2024
Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access AcademyFrancine Brinkhuis, Elaine Julian, Hendrika van den Ham, et al.Pharmacoepidemiology and Drug Safety|September 14, 2020
Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiativeLucinda S Orsini, Brigitta Monz, C Daniel Mullins, et al.Pageof 6